Suven Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 0.7 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Suven Life Sciences Limited has filed its quarterly financial results with the NSE for the quarter and nine months ended December 31, 2025. The headline confirms only the submission of results — actual revenue, profit, margin, and segment-wise numbers are not included in the provided text. Investors will need to review the full results PDF to assess revenue growth, operating profit, PAT, and any exceptional items. No auditor commentary, restatement notes, or going-concern flags were disclosed in the filing snippet provided.
For shareholders, this is a routine compliance filing confirming results have been disclosed on time. The actual stock reaction will depend on the underlying numbers (revenue trajectory, profitability, and any one-time items) in the detailed results document, which should be reviewed before drawing conclusions.